EarlyHealth Group Acquires 50% Stake in CYB3R to Boost Global Cybersecurity for Life Sciences

13 October 2025 | Monday | News

Strategic partnership expands CYB3R’s international footprint while safeguarding clinical studies, institutional programs, and government initiatives

EarlyHealth Group, a global pharmaceutical services and life sciences solutions company, has acquired a 50 % equity stake in CYB3R Limited, one of the Gulf’s fastest-growing cybersecurity firms headquartered in Dubai. This strategic diversification and cross-industry investment positions CYB3R with a global footprint whilst expanding its delivery of turnkey solutions to the life sciences industry and government organizations.

CYB3R, owned by tech entrepreneurs Alex Halsall and Jack Tupper, has rapidly gained prominence by securing critical infrastructure and sensitive data in regulated industries across the Middle East and Europe. By embedding CYB3R’s capabilities into EarlyHealth’s global platform, the partnership will scale operations internationally and deliver turnkey solutions that safeguard clinical studies, institutional programs, and government initiatives.

“With a growing portfolio of 1,200 international enterprises and public organizations, our partnership with EarlyHealth marks the next step in scaling CYB3R’s capabilities globally and delivering tailored cybersecurity solutions to our core sectors,” said Alex Halsall, Chief Executive Officer of CYB3R. “Together, we will establish a new benchmark for trusted, compliance-first digital security.”

CYB3R’s leadership team will remain in place post-acquisition, ensuring continuity in managing the current customer base while expanding its capabilities to serve new global markets.

EarlyHealth’s third acquisition this year underlines its drive to build a global conglomerate at the intersection of healthcare and digital transformation, delivering innovative solutions that expand access for patients, empower industry, and strengthen government capabilities worldwide.

 

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close